| Name | Title | Contact Details |
|---|---|---|
Holly Vance |
General Counsel | Profile |
Donna Cochener |
General Counsel | Profile |
Donna Cochener |
Interim Chief Executive Officer, Senior Vice President of Legal and General Counsel | Profile |
Leslie Aberman |
Vice President of Legal Affairs and Intellectual Property | Profile |
ONBIO Inc. is a Richmond Hill, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Solutions for isolation, recovery, and analysis of intact, individual rare cells. Single "cell sorter"
KalVista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.
Sonde Health is a digital medicine company developing a voice-based technology platform with the potential to transform the way we monitor and diagnose mental and physical health.
Quellis was founded to deliver best-in-class therapies to patients suffering serious rare diseases – and underserved by current treatment options. The Company is based in Boston, and is led by partners from the biotech incubator Viridian LLC in collaboration with team at biotech accelerator Xontogeny LLC, and with funding from the Perceptive Xontogeny Venture Fund. The Quellis team has deep experience in mAb discovery and development, company creation, and private and public biotech investment. Our shared goal is to create meaningful medicines for every disease we target.